Form drives function in cancer proliferation
A new study finds that the protein responsible for the crawling movements of cells also drives the ability of cancer cells to grow when under stress.
May 6, 2019
0
19
A new study finds that the protein responsible for the crawling movements of cells also drives the ability of cancer cells to grow when under stress.
May 6, 2019
0
19
Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published ...
May 3, 2019
0
69
Every year, nearly 11,000 Americans die of acute myeloid leukemia (AML), a blood cancer that affects mainly older adults. While most patients initially respond to chemotherapy, more than half of those who respond will eventually ...
Apr 25, 2019
0
2
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these positive outcomes are not long lasting, ...
Apr 15, 2019
0
3
Relapse of disease following conventional treatments remains one of the central problems in cancer management, yet few therapeutic agents targeting drug resistance and tolerance exist. New research conducted at the Cancer ...
Apr 8, 2019
0
91
Can exercise reduce the risk of heart disease in women with breast cancer?
Mar 29, 2019
0
12
Changing when you eat rather than what you eat may prove to be a dietary intervention against breast cancer, suggests a new mouse study to be presented Saturday at ENDO 2019, the Endocrine Society's annual meeting in New ...
Mar 25, 2019
0
4
A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast cancer.
Mar 12, 2019
0
752
The development of effective anti-androgen therapies for prostate cancer is a major scientific advance. However, some men who receive these targeted treatments are more likely to develop a deadly treatment-resistant prostate ...
Feb 28, 2019
0
36
(HealthDay)—Metastasis-free survival is significantly longer among men with nonmetastatic, castration-resistant prostate cancer treated with darolutamide versus placebo, according to a phase 3 study published online Feb. ...
Feb 19, 2019
0
1